无症状颈动脉狭窄患者应谨慎使用经股动脉颈动脉支架
基于血管质量倡议(2005-2017)数据,比较无症状颈动脉狭窄患者行颈动脉内膜剥脱术(CEA)与经股动脉颈动脉支架(CAS)的围手术期及2年卒中/死亡风险。重度(60-79%)与极重度(≥80%)狭窄组中,CAS的30天卒中/死亡风险在极重度组显著高于CEA(2.0% vs 1.2%,P<0.001),重度组无显著差异(1.7% vs 1.3%,P=0.17)。2年结局CAS风险仍较高。作者认为药物治疗应作为重度(60-79%)无症状狭窄患者卒中预防的一线方案。
要点
- 极重度(≥80%)狭窄组CAS的30天卒中/死亡粗发生率显著高于CEA(2.0% vs 1.2%,P<0.001)。
- 重度(60-79%)狭窄组CAS与CEA的30天卒中/死亡无显著差异(1.7% vs 1.3%,P=0.17)。
- 多变量分析显示极重度狭窄组CAS的30天卒中/死亡风险仍高于CEA(OR 1.64,95%CI 1.26-2.13)。
核心结论
- 超过三分之一因无症状颈动脉狭窄行颈动脉血运重建的患者为60-79%狭窄。
- 较低狭窄程度对CEA或CAS术后30天或2年卒中/死亡均无保护作用。
- 作者认为对于重度(60-79%)颈动脉狭窄的无症状患者,最佳药物治疗应作为卒中预防的一线方案。
研究设计与样本
- 回顾性队列研究,纳入血管质量倡议(2005-2017)中所有因无症状颈动脉狭窄行CEA或经股动脉CAS的患者,共53,337例(重度狭窄17,586例,占33.%)。
- 狭窄程度定义为任何影像学方法记录的最高值;重度为60-79%,极重度为≥80%。
- 采用单变量和多变量逻辑回归分析30天卒中、卒中/死亡和主要不良心脏事件(MACE);采用Cox比例风险、生命表和Kaplan-Meier估计评估术后2年同侧卒中及卒中/死亡。
主要发现
- 30天卒中/死亡粗发生率:极重度狭窄组CAS vs CEA为2.0% vs 1.2%(P<0.001);重度狭窄组CAS vs CEA为1.7% vs 1.3%(P=0.17)。
- MACE在两组中CAS与CEA均无显著差异(P≥0.64)。
- 多变量分析:极重度狭窄组CAS相比CEA的30天卒中或死亡风险持续较高(OR 1.64,95%CI 1.26-2.13)。
- CEA患者30天复合卒中/死亡风险在重度与极重度狭窄间相似(OR 1.07,95%CI 0.89-1.28),但重度狭窄组围手术期卒中风险有升高趋势(OR 1.23,95%CI 0.97-1.56)。
- 2年粗年化发生率:重度狭窄组CAS vs CEA卒中IRR 1.62(95%CI 1.00-2.55)、卒中/死亡IRR 1.53(95%CI 1.11-1.64);极重度狭窄组CAS vs CEA卒中IRR 1.97(95%CI 1.44-2.65)、卒中/死亡IRR 1.51(95%CI 1.34-1.68)(均P≤0.04)。
临床怎么用
- 作者认为对于重度(60-79%)颈动脉狭窄的无症状患者,最佳药物治疗应作为卒中预防的一线方案。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Significant national variation exists in defining the degree of stenosis that requires intervention in patients with asymptomatic carotid artery stenosis (ACAS). We aimed to evaluate the risk of perioperative and 2-year stroke and death in ACAS patients undergoing carotid endarterectomy (CEA) and carotid artery stenting (CAS) for severe versus very severe stenosis in a contemporary population. METHODS: All patients undergoing CEA or transfemoral CAS for ACAS in the Vascular Quality Initiative (2005-2017) were included. Degree of stenosis was defined as the highest recorded on any imaging method. Univariable and multivariate logistic regression analyses were performed to assess risk of stroke, stroke/death, and major adverse cardiac events (MACE) at 30 days; and Cox proportional hazard, life tables, and Kaplan-Meier estimates were implemented to evaluate ipsilateral stroke and stroke/death at 2 years postoperatively in patients undergoing CEA versus CAS for severe (60-79%) and very severe (≥80%) stenosis adjusting for baseline characteristics. RESULTS: A total of 53,337 ACAS patients were examined (severe stenosis = 17,586; 33.%), of which 11.5% (n = 6,127) underwent CAS. The crude incidence of 30-day stroke/death was significantly higher for CAS versus CEA in the very severe stenosis group (2.0% vs. 1.2%, P < 0.001), but not in the severe stenosis group (1.7% vs. 1.3%, P = 0.17). MACE was not significantly different for CAS versus CEA in either group (P ≥ 0.64). On multivariable analysis, CAS was associated with a persistently higher risk of 30-day stroke or death compared to CEA in patients with very severe stenosis (odds ratio [OR] 1.64, 95% confidence interval [CI] 1.26-2.13). The 30-day composite stroke/death risk for patients undergoing CEA was similar for severe versus very severe stenosis (OR 1.07, 95% CI 0.89-1.28), but there was a trend toward higher risk of perioperative stroke in the severe stenosis group (OR 1.23, 95% CI 0.97-1.56). Two-year outcomes were similar; the crude annualized incidence rates of stroke and stroke/death were higher for CAS versus CEA in both the severe (stroke: incidence rate ratio [IRR] 1.62, 95% CI 1.00-2.55; stroke/death: IRR 1.53, 95% CI 1.11-1.64) and very severe stenosis (stroke: IRR 1.97, 95% CI 1.44-2.65; stroke/death: IRR 1.51, 95% CI 1.34-1.68) groups (all, P ≤ 0.04). On multivariable Cox proportional hazards analysis, CAS was associated with a higher risk of stroke or death compared to CEA in patients with both severe (hazard ratio [HR] 1.40, 95% CI 1.15-1.70) and very severe stenosis (HR 1.62, 95% CI 1.37-1.90). CONCLUSIONS: More than one-third of patients undergoing carotid revascularization for ACAS had 60-79% stenosis. Having lower degree of stenosis is not protective against stroke and death for either CEA or CAS at either 30 days or 2 years postoperatively. We believe that optimal medical management should be the first line in stroke prevention for asymptomatic patients with severe (60-79%) carotid stenosis.
引用
- Hicks CW, Nejim B, Aridi HD, et al. Transfemoral Carotid Artery Stents Should Be Used with Caution in Patients with Asymptomatic Carotid Artery Stenosis. Ann Vasc Surg. 2018. PMID: 30339900. doi:10.1016/j.avsg.2018.10.001
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。